Jason Shafrin
Last week, the Federal Trade Commission (FTC) released a report titled “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies.” While I won’t get into an analysis of the specific arguments FTC made, the report does have a number of interesting statistics and graphics on pharmacy benefit managers (PBMs). Some highlights are below.
First, PBMs do much more than just design formularies. Now they are highly integrated entities, with many large PBMs being owned directly by health plans. …
